Takeda Pharmaceutical Company Limited Stock London S.E.
Stocks
0A87
US8740602052
Pharmaceuticals
OTC Markets Traded|
Market Closed -
London S.E.
10:43:50 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 18.55 USD | -0.70% |
|
-0.70% | +28.66% |
| Market Cap | 9,531B 60.57B 53.15B 50.19B 45.74B 85.63B 5,805B 86.24B 601B 233B 2,966B 227B 222B | P/E 2027 * |
47.3x | P/E 2028 * | 30x |
|---|---|---|---|---|---|
| Enterprise Value | 13,438B 85.39B 74.93B 70.77B 64.49B 121B 8,184B 122B 847B 328B 4,181B 321B 314B | EV / Sales 2027 * |
2.86x | EV / Sales 2028 * | 2.76x |
| Free-Float |
99.26% | Yield 2027 * |
3.42% | Yield 2028 * | 3.49% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| TAK | Delayed | |
CBOE
| TAK | Real-time | |
|
Tradegate
| TKDA | Real-time | |
|
London S.E.
| 0A87 | Delayed | |
|
Deutsche Boerse AG
| TKDA | Delayed | |
|
Börse Stuttgart
| TKDA | Delayed | |
|
Boerse Muenchen
| TKDA | Real-time |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -0.70% | ||
| 1 week | -0.70% | ||
| Current month | +17.41% | ||
| 1 month | +17.41% | ||
| 3 months | +17.41% | ||
| 6 months | +2.84% | ||
| Current year | +28.66% |
| 1 week | 18.55 |  | 18.55 |
| 1 month | 18.55 | | 18.68 |
| Current year | 15.67 | | 18.68 |
| 1 year | 14.05 | | 18.68 |
| 3 years | 12.59 | | 18.68 |
| 5 years | 12.3 | | 18.68 |
| 10 years | 12.3 | | 19.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2024-12-31 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 2024-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 2022-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 2015-05-31 |
Steven Gillis
BRD | Director/Board Member | 73 | 2018-12-31 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 2024-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.70% | -0.70% | - | - | 60.57B | |
| +0.13% | +2.65% | +65.61% | +114.28% | 1,055B | |
| +0.20% | +0.46% | +52.60% | +69.24% | 654B | |
| -0.29% | +0.14% | +20.96% | +70.93% | 467B | |
| -0.85% | +0.98% | +41.29% | +44.38% | 348B | |
| +0.71% | +4.08% | +22.24% | +29.51% | 275B | |
| +1.23% | +0.42% | +14.57% | +12.13% | 258B | |
| +2.11% | +7.51% | +52.89% | +55.37% | 224B | |
| +0.83% | +0.55% | +35.99% | +101.70% | 187B | |
| 0.00% | -10.14% | -29.94% | -60.30% | 171B | |
| Average | +0.25% | +0.74% | +30.69% | +48.58% | 404.26B | |
| Weighted average by Cap. | +0.01% | +1.32% | +41.54% | +67.83% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,704B 29.89B 26.23B 24.77B 22.57B 42.26B 2,865B 42.56B 296B 115B 1,464B 112B 110B | 4,794B 30.46B 26.73B 25.25B 23.01B 43.07B 2,920B 43.38B 302B 117B 1,492B 114B 112B |
| Net income | 196B 1.25B 1.1B 1.03B 943M 1.77B 120B 1.78B 12.38B 4.8B 61.14B 4.69B 4.59B | 323B 2.05B 1.8B 1.7B 1.55B 2.9B 197B 2.92B 20.34B 7.88B 100B 7.7B 7.53B |
| Net Debt | 3,907B 24.82B 21.78B 20.57B 18.75B 35.1B 2,379B 35.35B 246B 95.35B 1,216B 93.2B 91.19B | 3,702B 23.53B 20.64B 19.5B 17.77B 33.26B 2,255B 33.5B 233B 90.37B 1,152B 88.33B 86.42B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
- 0A87 Stock
Select your edition
All financial news and data tailored to specific country editions
